Results 1 to 10 of about 106,315 (216)
Minimally Invasive Glaucoma Surgery. [PDF]
Dtsch Arztebl IntApproximately 1.4 % of the German population aged 35 to 74 suffers from glaucoma, which is one of the more common causes of blindness. The only evidence-based treatment option at present is lowering the intraocular pressure. Modern minimally invasive surgical procedures hold out the prospect of lowering the intraocular pressure without the risk of ...
Voykov B, Prokosch V, Lübke J.
europepmc +8 more sources
Minimally invasive bleb surgery versus minimally invasive glaucoma surgery: a 12-month retrospective study [PDF]
Scientific ReportsThis study aimed to compare the IOP-lowering effectiveness and safety of standalone Preserflo MicroShunt and iStent 1st generation implantation combined with phacoemulsification in Caucasian patients with a 12-month follow-up period.
Joanna Konopińska +2 more
doaj +6 more sources
Minimally Invasive Glaucoma Surgery: A Review of the Literature [PDF]
Vision, 2023 Minimally invasive glaucoma surgery (MIGS) has emerged as a novel approach in the glaucoma treatment spectrum, offering a range of diverse procedures and devices aimed at reducing intraocular pressure (IOP).
Michael Balas, David J. Mathew
doaj +3 more sources
Advancing Glaucoma Care in Bangladesh With Minimally Invasive Glaucoma Surgery. [PDF]
CureusMinimally invasive glaucoma surgery (MIGS) is a cutting-edge approach to treating glaucoma that provides a range of techniques and technology to reduce intraocular pressure (IOP). An 80-year-old man with visually significant cataracts and primary open-angle glaucoma (POAG) underwent combined cataract surgery and TrabEx+ (MicroSurgical Technology ...
Iqbal MI, Osman F.
europepmc +4 more sources
Minimally Invasive Glaucoma Surgery—A Comprehensive Review
TNOA Journal of Ophthalmic Science and ResearchGlaucoma is a progressive and irreversible optic neuropathy that can lead to blindness if left untreated, with intraocular pressure (IOP) being the primary modifiable risk factor.
Devendra Maheshwari +3 more
doaj +5 more sources
Anticoagulation for Minimally Invasive Glaucoma Surgery: An American Glaucoma Society Survey. [PDF]
J GlaucomaPrécis: Perspectives and practice patterns regarding perioperative anticoagulation management and minimally invasive glaucoma surgery were queried among surgeons of American Glaucoma Society. Management varied based on surgeon preference and the type of procedure performed. Purpose:
Pradeep T +5 more
europepmc +4 more sources
Minimally Invasive Glaucoma Surgery (MIGS)
Delhi Journal of Ophthalmology, 2021 Glaucoma, a chronic progressive optic neuropathy, is the second leading cause of irreversible blindness world-wide. The only treatable risk factor till date is lowering of intra-ocular pressure (IOP), thus, being the mainstay of treatment.
Meena G Menon, Shalini
doaj +6 more sources
Translating Minimally Invasive Glaucoma Surgery Devices [PDF]
Clinical and Translational Science, 2020 Glaucoma is the leading cause of irreversible blindness with over 70 million people affected worldwide. The surgical management of glaucoma aims to lower intraocular pressure by increasing aqueous outflow facility.
Richard M.H. Lee +4 more
doaj +4 more sources
Minimally Invasive Glaucoma Surgery [PDF]
Advances in Ophthalmology and Optometry, 2010 Surgery in glaucoma has generally been reserved for those patients who have not been able to achieve sufficient intraocular pressure (IOP) control with eye drops or laser treatment.
Elie Dahan +6 more
semanticscholar +5 more sources
Minimally Invasive Glaucoma Surgery: Is It Here to Stay? [PDF]
Clin Exp OphthalmolThe advent of minimally invasive glaucoma surgery (MIGS) has expanded the treatment options available for glaucoma by providing options for reducing intraocular pressure without the serious complication profile associated with incisional glaucoma surgery.
Jain N, Fan Gaskin JC.
europepmc +2 more sources